Linked Life Data

8755694

Source:http://linkedlifedata.com/resource/pubmed/id/8755694

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1996-12-23
pubmed:abstractText
Atrial fibrillation is the most common cardiac arrhythmia and is usually responsible for symptoms requiring some treatment. Antiarrhythmic drugs are the first choice therapy, but their potential risks are significant. This together with their limited efficacy restricts their use. Antiarrhythmic drug use should be tailored; mainly according to the underlying heart disease. When reversion to sinus rhythm is not eligible, the adequate control of ventricular rate and the reduction of embolic risk are the therapeutic goals. Atrial flutter shows different behaviour regarding the very limited efficacy of antiarrhythmic drugs for reversion to and maintenance in sinus rhythm.
pubmed:language
spa
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0300-8932
pubmed:author
pubmed:issnType
Print
pubmed:volume
49 Suppl 2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
32-41
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
[Pharmacologic maintenance of sinusal rhythm and/or control of the ventricular response in patients with atrial fibrillation or flutter].
pubmed:affiliation
Servicio de Cardiología, Hospital Universitario 12 de Octubre, Madrid.
pubmed:publicationType
Journal Article, English Abstract